Consecutively, owing to the fact that such FAS alterations have only been detected previously in clear-cut cases of PCMZL, we favored the diagnosis of PCMZL in these two grey-zone cases. The gene discussed is FAS; the disease is primary cutaneous marginal zone B-cell lymphoma.